SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

DELTETTO, Noelia et al. Deficiencia de 3-hidroxiacil coA deshidrogenasa de cadena larga, asociación con HELLP y hallazgos en la espectroscopia por resonancia magnética. Arch. argent. pediatr. [online]. 2012, vol.110, n.4, pp. e63-e66. ISSN 0325-0075.

    1. Ibdah JA, Strauss AW, Zhao Y, Yamada J, Yang Z. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 2002;288(17): 2163-6. [ Links ]

    2. den Boer M, Wanders R, Morris A, Ijist L, et al. Long chain 3 hydroxyacyl coA dehydrogenase deficiency: clinical presentation and follow up of 50 patients. Pediatrics 2002;109(1):99-104. [ Links ]

    3. Ibdah, JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006;12(46):7397-404. [ Links ]

    4. Strauss AW, Shapiro S, Gibson B, Bennett MJ, et al. The molecular basis of pediatric long chain 3-hydroxyacyl- CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad SCI USA 1995;92(3):841-5. [ Links ]

    5. Idbah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, Strauss AW. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340(22):1723-31. [ Links ]

    6. Shih VE, Larson C, Wilkins-Haug LE, Levy HL, Browning MF. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006;107(1):115-20. [ Links ]

    7. Holub M, Stockler-Ipsiroglu S, Pollak A, Muhl A, et al. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome? Acta Paediatr 2005;94(1):48-52. [ Links ]

    8. Mütze S, Ahillen I, Rudnik-Schoeneborn S, Eggermann T, et al. Neither maternal nor fetal mutation (E474Q) in the alpha-subunit of the trifunctional protein is frequent in pregnancies complicated by HELLP syndrome. J Perinat Med 2007;35(1):76-8. [ Links ]

    9. Spiekerkoetter U. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. J Inherit Metab Dis 2010;33(5):527-32. [ Links ]

    10. Den Boer ME, Ijlst L, Wijburg F, Oostheim W, et al. Heterozygosity for the common LCHAD, mutation (1528G>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 2000;48(2):151-4. [ Links ]

    11. Mansouri A, Fromenty B, Durand F, Degott C, et al. Assessment of the prevalence of genetic metabolic defects in acute fatty liver of pregnancy. J Hepatol 1996;25(5):781-2. [ Links ]

    12. Cecil KM. MR Spectroscopy of metabolic disorders. Neuroimaging Clin N Am 2006;16(1):87-116.viii. [ Links ]

    13. Roomets E, Lundbom N, Pihko H, Heikkinen S, Tyni T. Lipids detected by brain MRS during coma caused by carnitine palmitoyltransferase 1 deficiency. Neurology 2000;67(8):1516-7. [ Links ]

    14. Pirgon O, Aydin K, Atabek ME. Proton magnetic resonance spectroscopy findings and clinical effects of montelukast sodium in a case with Sjögren-Larsson syndrome. J Child Neurol 2006;21(12):1092-5. [ Links ]

    15. Groenendaal F, Bianchi MC, Battini R, Tosetti M, et al. Proton magnetic resonance spectroscopy (1H-MRS) of the cerebrum in two young infants wirh Zellweger syndrome. Neuropediatrics 2001;32(1):23-7. [ Links ]